Australian Procedure Numbers for Orthopedic Biomaterials 2016 – MedPro

Australian Procedure Numbers for Orthopedic Biomaterials 2016 – MedPro

0

Bone graft substitutes are designed to fill bone voids, which eliminates the need for autograft harvesting of the patient’s own bone. Viscosupplementation products are injected directly into the affected knee joint to relieve pain caused by osteoarthritis. Growth factors are naturally occurring molecules in the body that mediate various cellular functions.

  • Year: 2016
  • Scope: 2012-2022
  • Region: Australia
  • Published Date: 03/01/2016
  • Pages: 33
  • Type: MedPro

Segments Covered in this Orthopedic Biomaterials Procedure Volume Research

This market study focuses specifically on the volume of procedures in the orthopedic biomaterials market. It includes analysis of procedures in the following segments:

  • Autograft Procedures
  • Allograft Procedures
  • DBM Procedures
  • Synthetic Procedures
  • Cervical Spine Procedures
  • Thoracolumbar Spine Procedures
  • Trauma Procedures
  • Hip Procedures
  • Knee Procedures
  • Foot/Ankle Procedures
  • CMF Procedures
  • Hyaluronic Acid Viscosupplementation Procedures

This data is then displayed over the forecast period, 2012-2022, outlining the exact growth rates for procedures in these segments. If you’re interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)

Our analysts meticulously research for 3 to 4 months to put together a suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore. For a deeper description on these product types click here or contact us to have a product consultant help you find the data you need.

Where Do We Get Orthopedic Biomaterials Procedure Data?

Our team of analysts has proprietary data that we’ve been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic biomaterials procedure volumes that influence and coincide with our overall market sizing.

Trends Affecting the Orthopedic Biomaterials Market

The orthopedic biomaterials market in Australia grew 7.3% in 2015, in-line with its historical growth but slower than in the previous two years. This is mainly due to the entry of major new products and their consecutive hyper growth in the period of 2012 to 2014. In fact, all three segments of the orthopedic biomaterials market had one major new product introduced during that period. The second best performing segment in 2015 was bone graft substitutes, growing 7.1% that year, down from its 16.8% growth in 2014. This segment consists of three sub-segments: allografts, synthetics and demineralized bone matrices. The allograft and synthetic sub-segments largely performed in-line with their historical trends, while DBM continued to outperform them due to the recent entry of the very first commercial product in Australia

Questions This Report will Help You Answer

  • What is affecting the volume of procedures in Australia?
  • How many procedures were done in 2015?
  • How many procedures were done historically?
  • How many procedures can we expect in 2022 and what is the growth trend?


The "Australian Market Report Suite for Orthopedic Biomaterials 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Austofix
Austspine
Baxter
Bioventus
Bone Banks
Cerapedics
DePuy Synthes
Emergo Asia Pacific
Genzyme (Sanofi)
Global Orthopaedic
LMT Surgical
Medtronic
Nuvasive
Prism Surgical Designs
Scient'x Australia
Signature Orthopaedics
Smith & Nephew
Stryker
Surgiplas Medical
Wright Medical
Zimmer Biomet

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link